ECM
FENC icon

ExodusPoint Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

ExodusPoint Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-17,115
Closed -$125K – 2266
2021
Q2 		$125K Buy
+17,115
New +$114K ﹤0.01% 2102

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ExodusPoint Capital Management's FENC Position: Q3 2021 in Review

ExodusPoint Capital Management sold out of Fennec Pharmaceuticals (FENC) in Q3 2021, closing a stake of 17,115 shares — an estimated $125K sold.

ExodusPoint Capital Management first reported a position in FENC in Q2 2021 and held it in 1 quarter. The position peaked at $125K in Q2 2021. 32 funds tracked by Wall St. Rank hold FENC as of Q3 2021.

  • ExodusPoint Capital Management reported no remaining Fennec Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • ExodusPoint Capital Management sold 17,115 Fennec Pharmaceuticals shares in Q3 2021, an estimated $125K.
  • ExodusPoint Capital Management first reported a position in Fennec Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • ExodusPoint Capital Management's Fennec Pharmaceuticals position peaked at $125K in Q2 2021.
  • 32 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.